Dynex Capital, Inc., a mortgage real estate investment trust, invests in mortgage-backed securities (MBS) in the United States. It invests in agency MBS consisting of residential MBS and commercial MBS (CMBS); and agency and non-agency CMBS interest-only securities. Agency MBS have a guaranty of principal payment by an agency of the U.S. government or a U.S. government-sponsored entity, such as Fannie Mae and Freddie Mac. Non-Agency MBS do not have a guaranty of principal or interest payments. The company has qualified as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal income taxes if it distributes at least 90% of its taxable income to its shareholders. Dynex Capital, Inc. was incorporated in 1987 and is headquartered in Glen Allen, Virginia.

Dynex Capital Inc.

The latest update is out from Dynex Capital ( ($DX) ). On July 28, 2026, Dynex Capital, Inc. amended its existing at-the-market equity distribution...

Dynex Capital Expands At-The-Market Equity Program

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has issued an update. Lumos Diagnostics Holdings Ltd has disclosed a change in the shareholdings of d...

Lumos Diagnostics Updates Market on Director Doug Ward’s Increased Shareholding

Co-Diagnostics ( ($CODX) ) just unveiled an announcement. On July 27, 2026, Co-Diagnostics amended its October 20, 2025 equity distribution agreeme...

Co-Diagnostics Amends Equity Distribution, Extends Issuance Limits

There’s a lot to be optimistic about in the Energy sector as 2 analysts just weighed in on COSCO SHIPPING Energy Transportation Co (CSDXF) and Bake...

Analysts Are Bullish on These Energy Stocks: COSCO SHIPPING Energy Transportation Co (CSDXF), Baker Hughes Company (BKR)

Codexis ( ($CDXS) ) has shared an announcement. On July 23, 2026, Codexis, Inc. entered into an underwriting agreement with Piper Sandler & Co. and...

Codexis completes public equity offering to bolster liquidity

Amundi SA ( ($FR:AMUN) ) has shared an announcement. Amundi SA has continued to execute its 2026 share buyback program, reporting transactions on i...

Amundi Details July Transactions Under 2026 Share Buyback Program

Redox Limited ( ($AU:RDX) ) has issued an update. Redox Limited has scheduled its 2026 Annual General Meeting to be held as a hybrid event at Swiss...

Redox Sets Dates for 2026 AGM and Director Nomination Cut-Off

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) just unveiled an announcement. Lumos Diagnostics has released an investor presentation ahead of a roa...

Lumos Diagnostics Launches Investor Roadshow and Quarterly Results Webinar

Opthea ( ($AU:CYV) ) has shared an announcement. Ceryvyn Therapeutics reported quarterly progress marked by the reinstatement of its securities to ...

Ceryvyn Therapeutics Advances LAM Program After ASX Trading Reinstatement

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) just unveiled an update. Lumos Diagnostics reported a solid full-year performance for FY26, driven by...

Lumos Diagnostics FY26 Revenue Rises on FebriDx Surge Despite Services Slowdown

Key large-cap stock indexes closed down for the second consecutive week, as a combination of AI capex jitters and continued warfare in Iran weighed...

The AI Capex Reckoning: Markets Wobble as Google Spending Swells

Stocks ended the week mixed as strength in blue-chip shares offset losses in technology and semiconductor stocks. The Dow Jones Industrial Average ...

The Week That Was, The Week Ahead: Macro and Markets, July 26

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Celldex (CLDX) with bullish sent...

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

MDxHealth ( ($MDXH) ) has provided an announcement. On July 20, 2026, MDxHealth received an additional notice from Nasdaq after its market value of...

MDxHealth Faces New Nasdaq Warning Over Market Value Shortfall

The latest announcement is out from FedEx ( ($FDX) ). On July 20, 2026, FedEx’s board approved a new Executive Severance Plan governing all future ...

FedEx Adopts New Executive Severance and Consulting Plan

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Graco (GGG), Union Pacific (UNP) and FedEx (FDX). Graco (GG...

Analysts Offer Insights on Industrial Goods Companies: Graco (GGG), Union Pacific (UNP) and FedEx (FDX)

Codexis ( ($CDXS) ) has shared an update. Codexis disclosed a brief regulatory update indicating that the information previously reported under Ite...

Codexis Issues Brief Regulatory Filing Update Notice

The latest update is out from GridAI Technologies ( ($GRDX) ). On July 17, 2026, GridAI Technologies Corp. extended a $2 million secured convertibl...

GridAI Technologies Extends Secured Convertible Loan to Pronghorn

Integral Diagnostics Ltd. ( ($AU:IDX) ) has issued an update. Integral Diagnostics has re‑issued its notice to investors after a corrupted link in ...

Integral Diagnostics Resets FY26 Results Call After Link Issue

In a report released yesterday, from Berenberg Bank maintained a Hold rating on Sodexo SA, with a price target of €50.00. The company’s shares clos...

Berenberg Bank Remains a Hold on Sodexo SA (0J3F)

medmix AG ( ($CH:MEDX) ) just unveiled an update. medmix AG reported a 1.6% organic revenue decline to CHF 214.4 million in the first half of 2026 ...

medmix boosts margins and cash flow despite softer H1 revenue

Integral Diagnostics Ltd. ( ($AU:IDX) ) has shared an announcement. Integral Diagnostics Limited has scheduled the release of its fiscal year 2026 ...

Integral Diagnostics sets date for FY26 results release and investor call

The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On July 21, 2026, Bluejay Diagnostics announced it had completed patient enrol...

Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vanda (VNDA) and Celldex (CLDX) with bullish sentime...

Analysts Are Bullish on Top Healthcare Stocks: Vanda (VNDA), Celldex (CLDX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN), Celldex (CLDX) and Nurix Therapeut...

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Celldex (CLDX) and Nurix Therapeutics (NRIX)

Wells Fargo analyst Derek Archila maintained a Buy rating on Celldex yesterday and set a price target of $48.00. The company’s shares closed yester...

Wells Fargo Keeps Their Buy Rating on Celldex (CLDX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Helus Pharma (HELP) and Celldex (CLDX) with bullish ...

Analysts Offer Insights on Healthcare Companies: Helus Pharma (HELP) and Celldex (CLDX)

Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Syndax Pharmaceuticals today and set a price target of $29.00. Accordi...

Bank of America Securities Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CSL (CMXHF), Danaher (DHR) and TransMedics Group (TM...

Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Danaher (DHR) and TransMedics Group (TMDX)

Bell Potter analyst Martyn Jacobs maintained a Buy rating on Lumos Diagnostics Holdings Ltd. today and set a price target of A$0.25. Jacobs covers ...

Lumos Diagnostics Holdings Ltd. (LDX) Gets a Buy from Bell Potter

ADX Energy ( ($AU:ADX) ) has shared an update. ADX Energy Ltd has notified the ASX of a proposed securities issue, outlining plans for a substantia...

ADX Energy Plans Major Share and Options Placement on ASX

An update from ADX Energy ( ($AU:ADX) ) is now available. ADX Energy has secured firm commitments to raise A$3.58 million through a discounted shar...

ADX Energy raises A$3.58m to accelerate European oil and gas growth

In a report released yesterday, Jason Weaver from JonesTrading reiterated a Buy rating on Dynex Capital, with a price target of $14.75. According t...

JonesTrading Keeps Their Buy Rating on Dynex Capital (DX)

An announcement from Hines Global Income Trust, Inc. Class D ( ($ZHGIDX) ) is now available. On July 21, 2026, Hines Global Income Trust acquired t...

Hines Global Income Trust Acquires Charlotte Mixed-Use Asset

CNBC’s Jim Cramer says the market around artificial intelligence has become too concentrated and unpredictable to keep throwing new money into tech...

‘You’re Going to Be Slaughtered,’ Warns Jim Cramer to Tech Investors Before Intel, Tesla, and Alphabet Earnings

Gold may be getting a stronger underlying price floor than many traders realize, according to a new Goldman Sachs ($GS) note that says central bank...

Goldman Says Gold Could Reach $4,900 as Central Banks Keep Buying

MA Financial Group analyst Murray Connellan maintained a Buy rating on Dexus Industria REIT yesterday and set a price target of A$3.30. Connellan c...

Dexus Industria REIT (DXI) Receives a Buy from MA Financial Group

COSCO SHIPPING Energy Transportation Co ( ($HK:1138) ) has provided an announcement. COSCO SHIPPING Energy Transportation Co., Ltd., a major Chines...

COSCO SHIPPING Energy Wins EGM Backing and Adds New Executive Director

COSCO SHIPPING Energy Transportation Co ( ($HK:1138) ) has provided an update. COSCO SHIPPING Energy Transportation Co., Ltd. has announced the lat...

COSCO SHIPPING Energy Transportation Updates Board and Committee Structure

Barclays analyst Etzer Darout assigned a Buy rating to Syndax Pharmaceuticals today and set a price target of $37.00. According to TipRanks, Darout...

Syndax Pharmaceuticals (SNDX) Receives a New Rating from a Top Analyst

Gold and silver are holding important support zones after a volatile week, with both metals rebounding as softer U.S. inflation data and a weaker d...

Gold and Silver Hold Key Support as Inflation and Dollar Pressure Ease

Markets were pulled in different directions last week by conflicting macro, geopolitical, broad market, industry-specific, and individual company f...

When Guns Fire, the Music Stops: AI Rally Hits Its Shakiest Week

In a report released on July 17, Matt Hewitt from Craig-Hallum maintained a Buy rating on Codexis. The company’s shares closed last Friday at $2.24...

Craig-Hallum Reaffirms Their Buy Rating on Codexis (CDXS)

Stocks ended the week lower as weakness in technology shares and disappointing corporate outlooks weighed on the major U.S. indexes. The Dow Jones ...

The Week That Was, The Week Ahead: Macro and Markets, July 19

In a report released on July 16, Craig Wong-Pan from RBC Capital maintained a Buy rating on Integral Diagnostics Ltd., with a price target of A$2.8...

RBC Capital Reaffirms Their Buy Rating on Integral Diagnostics Ltd. (IDX)

Morgan Stanley analyst Jamie Rollo maintained a Sell rating on Sodexo SA today and set a price target of €50.00. Rollo covers the Consumer Cyclical...

Sodexo SA (0J3F) Receives a Sell from Morgan Stanley

An update from Hines Global Income Trust, Inc. Class D ( ($ZHGIDX) ) is now available. Hines Global Income Trust reported a net asset value of $3.0...

Hines Global Income Trust Announces July 2026 Distributions

Micron ($MU) shares fell 5.7% today even though the memory chipmaker announced a major set of long‑term auto agreements with several major automoti...

Why Is Micron Stock (MU) Down Despite Its Major Auto Chip Deal?

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lineage Therap (LCTX), Syndax Pharmaceuticals (SNDX)...

Analysts’ Top Healthcare Picks: Lineage Therap (LCTX), Syndax Pharmaceuticals (SNDX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Syndax Pharmaceuticals (SNDX) and Rhythm Pharmaceuti...

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Rhythm Pharmaceuticals (RYTM)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Syndax Pharmaceuticals (SNDX) and HCA Healthcare (...

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and HCA Healthcare (HCA)

The Magnificent Seven have driven much of the market’s gains over the past few years. Now, JPMorgan ($JPM) believes investors may want to look beyo...

Forget the Magnificent Seven. Here Are 3 ‘Strong Buy’ Small-Cap Stocks as JPMorgan Turns Bullish

Quantum computing stocks rebounded on Tuesday, July 14, following an extended sell-off, as cooler U.S. inflation data helped revive demand for spec...

Quantum Stocks Rebound as Cooler Inflation Lifts IONQ, QBTS, RGTI, and QUBT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on HCA Healthcare (HCA) and Syndax Pharmaceuticals (SNDX). Syndax Ph...

Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA) and Syndax Pharmaceuticals (SNDX)

An announcement from Pluri ( ($PLUR) ) is now available. Pluri Inc. previously secured a finance agreement with the European Investment Bank for up...

Pluri in ongoing talks to extend EIB financing

An update from Dexus ( ($AU:DXS) ) is now available. Dexus has provided an update on ongoing legal proceedings related to the APAC matter involving...

Dexus sets October court date in escalating APAC appeals battle

BCAL Diagnostics Limited ( ($AU:BDX) ) has shared an announcement. BCAL Diagnostics Limited has notified the market of the issue of 1,000,000 unquo...

BCAL Diagnostics Issues 1 Million Unquoted Convertible Notes

BCAL Diagnostics Limited ( ($AU:BDX) ) has issued an update. BCAL Diagnostics Limited has notified the market of the issue of 100,000 unquoted conv...

BCAL Diagnostics Issues 100,000 Unquoted Convertible Notes

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has issued an announcement. Lumos Diagnostics Holdings Ltd. has notified the market that 43,000 perfo...

Lumos Diagnostics Reports Lapse of 43,000 Performance Rights

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Dexcom, with a price target of $85.00. Singh Chadha...

RBC Capital Keeps Their Buy Rating on Dexcom (DXCM)

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Hold rating on Becton Dickinson, with a price target of $175.00. ...

RBC Capital Remains a Hold on Becton Dickinson (BDX)

In a report released on July 11, from HSBC maintained a Hold rating on COSCO SHIPPING Energy Transportation Co, with a price target of HK$12.60. Th...

HSBC Sticks to Its Hold Rating for COSCO SHIPPING Energy Transportation Co (CSDXF)

An update from Pluri ( ($PLUR) ) is now available. On July 7, 2026, Pluri Inc. disclosed that it had received a notice from Nasdaq stating the comp...

Pluri Receives Nasdaq Non-Compliance Notice, Faces Delisting Risk

Hines Global Income Trust, Inc. Class D ( ($ZHGIDX) ) has shared an announcement. On July 13, 2026, Hines announced that Hines Global Income Trust ...

Hines Global Income Trust Expands with Office and Retail Acquisitions

Becton, Dickinson and Co ($BDX) announced an update on their ongoing clinical study. The UK PureWick™ At-Home Pilot Study aims to test a new way fo...

BDX Advances Home Urinary Care With UK PureWick™ At-Home Pilot Study

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Me...

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

In a report released today, from Wedbush maintained a Buy rating on Ardelyx, with a price target of $19.00. The word on The Street in general, sugg...

Ardelyx (ARDX) Receives a Buy from Wedbush

After SpaceX’s ($SPCX) high-profile IPO last month, investors are looking for ways to get exposure to the company’s fast growth in launch services,...

Looking for Exposure to SpaceX Stock (SPCX)? Consider These Two ETFs

The first full trading week of H2 2026 was anything but calm. The Iran conflict returned to the forefront, the Fed revealed a more hawkish inclinat...

Memory Games: SK Hynix Mega-Listing Extends the AI Chip Rally

Stocks ended the week higher as continued enthusiasm for AI and technology shares helped lift the major U.S. indexes. The Dow Jones Industrial Aver...

The Week That Was, The Week Ahead: Macro and Markets, July 12

FedEx ( ($FDX) ) just unveiled an announcement. On July 10, 2026, FedEx announced early results of its cash tender offers for a broad slate of long...

FedEx Reshapes Debt After FedEx Freight Spin-Off

An update from Audax Renovables SA ( ($ES:ADX) ) is now available. Audax Renovables has secured a new revolving financing agreement of up to 75 mil...

Audax Renovables Secures €75 Million Revolving Credit to Bolster Liquidity

An update from COSCO SHIPPING Energy Transportation Co ( ($HK:1138) ) is now available. COSCO SHIPPING Energy Transportation Co. forecasts unaudite...

COSCO SHIPPING Energy Sees 141% Profit Surge on Booming Oil Freight Market

Berenberg Bank analyst Davide Amorim reiterated a Buy rating on JCDecaux SA yesterday and set a price target of €28.00. The company’s shares closed...

Berenberg Bank Keeps Their Buy Rating on JCDecaux SA (0MGO)

4DMedical Ltd ( ($AU:4DX) ) has shared an update. Following the recent exercise of options under its Long Term Incentive Plan, 4DMedical has issued...

4DMedical Issues New Shares on Option Exercise, Affirms Regulatory Compliance

4DMedical Ltd ( ($AU:4DX) ) has provided an announcement. 4DMedical Ltd has applied for quotation on the ASX for 1,632,125 new ordinary fully paid ...

4DMedical Adds 1.63 Million New Shares to ASX Quotation

4DMedical Ltd ( ($AU:4DX) ) just unveiled an update. 4DMedical Ltd has applied for the quotation of additional ordinary fully paid shares on the AS...

4DMedical Expands ASX-Quoted Share Base Through New Issuance

Shares of SpaceX ($SPCX), the aerospace and satellite company led by Elon Musk, have plunged about 35% from their post-IPO peak. The decline has wi...

SpaceX Stock (SPCX) Craters 35% From Peak as Musk Loses $50B in One Day

There’s a lot to be optimistic about in the Industrial Goods sector as 2 analysts just weighed in on Nordex (NRDXF) and CSX (CSX) with bullish sent...

Analysts Offer Insights on Industrial Goods Companies: Nordex (OtherNRDXF) and CSX (CSX)

The latest announcement is out from medmix AG ( ($CH:MEDX) ). Medmix has expanded its dental portfolio with FleXa, a customizable syringe platform ...

Medmix launches customizable FleXa syringe platform to boost dental precision and branding

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Nordex (NRDXF) and Granite Construction (GVA...

Analysts Offer Insights on Industrial Goods Companies: Nordex (OtherNRDXF) and Granite Construction (GVA)

In a report released yesterday, Michael Sanderson from Barclays assigned a Hold rating to Amundi SA. The company’s shares closed last Tuesday at €8...

Amundi SA (0RDX) Gets a Hold from Barclays

Destination XL ( ($DXLG) ) just unveiled an announcement. On July 8, 2026, Destination XL Group, Inc. announced that its board of directors unanimo...

Destination XL Board Rejects Revised Zodiac Tender Offer

In a report released today, James Tate CFA from Goldman Sachs maintained a Hold rating on JCDecaux SA, with a price target of €21.50. According to ...

JCDecaux SA (0MGO) Gets a Hold from Goldman Sachs

The latest update is out from GSH ( ($SG:BDX) ). GSH Corporation has disclosed a renewed arbitration move against its subsidiary Investasia Sdn. Bh...

GSH Faces Renewed RM143.2 Million Arbitration Claim Against Subsidiary

In a report released on July 6, Joanne Wuensch from Citi reiterated a Buy rating on Dexcom, with a price target of $84.00. The company’s shares clo...

Dexcom (DXCM) Receives a Buy from Citi

In a report released on July 6, Joanne Wuensch from Citi reiterated a Buy rating on Becton Dickinson, with a price target of $198.00. The company’s...

Citi Reaffirms Their Buy Rating on Becton Dickinson (BDX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dexcom (DXCM) and Vera Therapeutics (VERA) with bull...

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM) and Vera Therapeutics (VERA)

Addex Therapeutics ( ($CH:ADXN) ) just unveiled an announcement. Addex Therapeutics has reported new preclinical data showing that ADX71743, a sele...

Addex bolsters mGlu7 program with new ADX71743 sleep and stress data

In a report released today, Liam Schofield from Morgans maintained a Hold rating on Dexus Industria REIT, with a price target of A$2.44. Schofield ...

Dexus Industria REIT (DXI) Receives a Hold from Morgans

Morgans analyst Liam Schofield maintained a Hold rating on Dexus Convenience Retail REIT today and set a price target of A$2.60. According to TipRa...

Dexus Convenience Retail REIT (DXC) Receives a Hold from Morgans

In a report released today, Jamie Rollo from Morgan Stanley maintained a Sell rating on Sodexo SA, with a price target of €50.00. According to TipR...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Dyadic International (DYAI) and Idexx Laboratories...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Dyadic International (DYAI) and Idexx Laboratories (IDXX)

Dexus ( ($AU:DXS) ) just unveiled an update. Dexus has announced the cessation of 48,493 performance rights, recorded under the ASX security code D...

Dexus Cancels 48,493 Unvested Performance Rights After Conditions Lapse

Dexus ( ($AU:DXS) ) has provided an update. Dexus has notified the market of the issue and transfer of 567,463 fully paid units in its stapled secu...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DX	$12.83	+1.46%	2.49M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DX	$12.83	+1.5%	2.49M
3
4
5
6

DX

DX

Get Dynex Capital Inc. Data in Excel

Get Dynex Capital Inc. Data in Excel